Favourable response to rituximab by an ocular adnexal primary lymphoma.
| Autor: | Luque Valentin-Fernandez ML; Sección de Oftalmología, Hospital El Escorial, San Lorenzo de El Escorial, Madrid, España. Electronic address: marisa.luque@yahoo.es., Alvarez Rodríguez F; Servicio de Anatomía Patológica, Hospital Universitario Infanta Leonor, Madrid, España., Rodríguez Jiménez I; Servicio de Radiodiagnóstico, Hospital Universitario El Escorial, San Lorenzo de El Escorial, Madrid, España. |
|---|---|
| Jazyk: | English; Spanish; Castilian |
| Zdroj: | Archivos de la Sociedad Espanola de Oftalmologia [Arch Soc Esp Oftalmol] 2016 Nov; Vol. 91 (11), pp. 539-542. Date of Electronic Publication: 2016 Apr 25. |
| DOI: | 10.1016/j.oftal.2016.03.015 |
| Abstrakt: | Case Report: A 70-year-old woman who presented with an extranodal marginal zone B-cell lymphoma in lacrimal gland and conjunctiva. Initial treatment with rituximab yielded an immediate good response. Five months later she showed lymphoid proliferation in her contralateral conjunctiva. Although no additional treatment was performed, the patient has been free of systemic symptoms and recurrences. Discussion: Rituximab is a quite good therapeutic agent in low grade adnexal lymphomas. (Copyright © 2016 Sociedad Española de Oftalmología. Publicado por Elsevier España, S.L.U. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|